Your browser doesn't support javascript.
loading
Factors predictive of leg-ulcer healing in sickle cell disease: a multicentre, prospective cohort study.
Senet, P; Blas-Chatelain, C; Levy, P; Manea, E M; Peschanski, M; Mirault, T; Stankovic-Stojanovic, K; Debure, C; Debbache, K; Girot, R; Bureau, J-M; Bachmeyer, C; Baldeschi, C; Galacteros, F; Lionnet, F; Gellen-Dautremer, J.
Affiliation
  • Senet P; Service de Dermatologie, Hôpital Tenon, Assistance Publique-Hôpitaux de Paris (APHP), 4 Rue de la Chine, Paris CEDEX 20, 75970, France.
  • Blas-Chatelain C; Service de Rééducation Vasculaire, Hôpital Corentin-Celton, APHP, 4 Parvis Corentin-Celton, BP 66, Issy-les-Moulineaux CEDEX, 92133, France.
  • Levy P; Service de Santé Publique, Hôpital Tenon, APHP, Université Pierre et Marie Curie and Institut National de la Santé et de la Recherche Médicale, UMR-S 1136, Paris, France.
  • Manea EM; Unité des Maladies Génétiques du Globule Rouge, Service de Médecine Interne, Centre de Référence de la Drépanocytose, Hôpital Henri-Mondor, APHP and Université Paris-Est Créteil, Créteil, France.
  • Peschanski M; Inserm/UEVE UMR 861, I-Stem, AFM, Génopôle Campus 1, Évry, France.
  • Mirault T; Service de Rééducation Vasculaire, Hôpital Corentin-Celton, APHP, 4 Parvis Corentin-Celton, BP 66, Issy-les-Moulineaux CEDEX, 92133, France.
  • Stankovic-Stojanovic K; Service de Médecine Interne, Centre de Référence de la Drépanocytose, Hôpital Tenon, APHP and Université Pierre et Marie Curie, Paris, France.
  • Debure C; Service de Rééducation Vasculaire, Hôpital Corentin-Celton, APHP, 4 Parvis Corentin-Celton, BP 66, Issy-les-Moulineaux CEDEX, 92133, France.
  • Debbache K; Unité des Maladies Génétiques du Globule Rouge, Service de Médecine Interne, Centre de Référence de la Drépanocytose, Hôpital Henri-Mondor, APHP and Université Paris-Est Créteil, Créteil, France.
  • Girot R; Service de Médecine Interne, Centre de Référence de la Drépanocytose, Hôpital Tenon, APHP and Université Pierre et Marie Curie, Paris, France.
  • Bureau JM; Service de Rééducation Vasculaire, Hôpital Corentin-Celton, APHP, 4 Parvis Corentin-Celton, BP 66, Issy-les-Moulineaux CEDEX, 92133, France.
  • Bachmeyer C; Service de Médecine Interne, Centre de Référence de la Drépanocytose, Hôpital Tenon, APHP and Université Pierre et Marie Curie, Paris, France.
  • Baldeschi C; Inserm/UEVE UMR 861, I-Stem, AFM, Génopôle Campus 1, Évry, France.
  • Galacteros F; Unité des Maladies Génétiques du Globule Rouge, Service de Médecine Interne, Centre de Référence de la Drépanocytose, Hôpital Henri-Mondor, APHP and Université Paris-Est Créteil, Créteil, France.
  • Lionnet F; Service de Médecine Interne, Centre de Référence de la Drépanocytose, Hôpital Tenon, APHP and Université Pierre et Marie Curie, Paris, France.
  • Gellen-Dautremer J; Service de Médecine Interne et Maladies Infectieuses, Centre Hospitalier Universitaire Poitires, 86021, Poitiers, France.
Br J Dermatol ; 177(1): 206-211, 2017 Jul.
Article in En | MEDLINE | ID: mdl-27992062
ABSTRACT

BACKGROUND:

Leg ulcers (LUs) are a chronic and severe complication of sickle cell disease (SCD). A prospective study in patients with SCD to identify factors associated with complete healing and recurrence of LUs is lacking.

OBJECTIVES:

To determine clinical and biological factors associated with SCD-LU complete healing and recurrence.

METHODS:

This prospective, observational cohort study was conducted at two adult SCD referral-centre sites (2009-2015) and included 98 consecutive patients with at least one LU lasting ≥ 2 weeks. The primary end points compared patients with healed vs. nonhealed LUs at week 24, and patients with vs. without recurrence during follow-up.

RESULTS:

The median (interquartile range) LU area, duration and follow-up were, respectively, 6·2 cm2 (3-12·8), 9 weeks (4-26) and 65·8 weeks (23·8-122·1). At week 24, LUs were healed in 47% of patients, while 49% of LUs recurred. Univariate analyses identified inclusion LU area < 8 cm2 (82% vs. 35%; P < 0·001), inclusion LU duration < 9 weeks (65% vs. 35%; P = 0·0013) and high median fetal haemoglobin level (P = 0·008) as being significantly associated with complete healing at week 24, and low lactate dehydrogenase level (P = 0·038) as being associated with recurrence. Multivariate analyses retained LU area < 8 cm2 (odds ratio 6·73, 95% confidence interval 2·35-19. 31; P < 0·001) and < 9 weeks' duration (OR 3·19, 95% confidence interval 1·16-8·76; P = 0·024) as being independently associated with healing at week 24. Factors independently associated with recurrence could not be identified.

CONCLUSIONS:

SCD-LU complete healing is independently associated with the clinical characteristics of LUs rather than the clinical or biological characteristics of SCD.
Subject(s)

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Wound Healing / Anemia, Sickle Cell / Leg Ulcer Type of study: Clinical_trials / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Female / Humans / Male Language: En Journal: Br J Dermatol Year: 2017 Document type: Article Affiliation country: Francia

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Wound Healing / Anemia, Sickle Cell / Leg Ulcer Type of study: Clinical_trials / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Female / Humans / Male Language: En Journal: Br J Dermatol Year: 2017 Document type: Article Affiliation country: Francia
...